ING Group’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20,266
Closed -$1.13M 628
2025
Q3
$1.13M Buy
+20,266
New +$1.09M 0.01% 426
2025
Q1
Sell
-20,294
Closed -$1.46M 599
2024
Q4
$1.46M Buy
+20,294
New +$1.49M 0.01% 454
2023
Q4
Sell
-65
Closed -$4.42K 653
2023
Q3
$4.42K Sell
65
-1,835
-97% -$145K ﹤0.01% 610
2023
Q2
$155K Sell
1,900
-4,236
-69% -$340K ﹤0.01% 487
2023
Q1
$455K Buy
+6,136
New +$473K ﹤0.01% 473
2022
Q3
Sell
-4,732
Closed -$410K 530
2022
Q2
$410K Buy
+4,732
New +$443K ﹤0.01% 499
2022
Q1
Sell
-20,512
Closed -$2.65M 604
2021
Q4
$2.65M Buy
20,512
+7,452
+57% +$914K 0.02% 423
2021
Q3
$1.58M Buy
+13,060
New +$1.59M 0.02% 423
2019
Q3
Sell
-8,420
Closed -$439K 721
2019
Q2
$439K Buy
8,420
+72
+0.9% +$3.63K 0.01% 554
2019
Q1
$414K Sell
8,348
-8
-0.1% -$360 0.01% 507
2018
Q4
$302K Buy
+8,356
New +$349K 0.01% 587
2018
Q2
Sell
-9,600
Closed -$362K 851
2018
Q1
$362K Buy
9,600
+188
+2% +$6.64K 0.01% 563
2017
Q4
$305K Buy
+9,412
New +$299K 0.01% 641

Other funds holding TECH

ING Group's TECH Position: Q4 2025 in Review

ING Group sold out of Bio-Techne (TECH) in Q4 2025, closing a stake of 20,266 shares — an estimated $1.13M sold.

ING Group first reported a position in TECH in Q4 2017 and held it in 13 quarters. The position peaked at $2.65M in Q4 2021. 585 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

  • ING Group reported no remaining Bio-Techne position as of Q4 2025 after selling out during the quarter.
  • ING Group sold 20,266 Bio-Techne shares in Q4 2025, an estimated $1.13M.
  • ING Group first reported a position in Bio-Techne in Q4 2017 and held it in 13 quarters.
  • ING Group's Bio-Techne position peaked at $2.65M in Q4 2021.
  • 585 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on ING Group's 13F filing for Q4 2025, filed 11 Feb 2026.